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Abstract
Background: Glioblastoma is the most common tumor of the central nervous system and one of the hardest
tumors to treat. Consequently, the search for novel therapeutic options is imperative. 7-epiclusianone, a tetraprenylated
benzophenone isolated from the epicarp of the native plant Garcinia brasiliensis, exhibits a range of biological activities
but its prospect anticancer activity is underexplored. Thus, the aim of the present study was to evaluate the influence
of 7-epiclusianone on proliferation, clonogenic capacity, cell cycle progression and induction of apoptosis in two
glioblastoma cell lines (U251MG and U138MG).
Methods: Cell viability was measured by the MTS assay; for the clonogenic assay, colonies were stained with Giemsa
and counted by direct visual inspection; For cell cycle analysis, cells were stained with propidium iodide and analyzed
by cytometry; Cyclin A expression was determined by immunoblotting; Apoptotic cell death was determined by
annexin V fluorescein isothiocyanate labeling and Caspase-3 activity in living cells.
Results: Viability of both cell lines was drastically inhibited; moreover, the colony formation capacity was significantly
reduced, demonstrating long-term effects even after removal of the drug. 7-epiclusianone treatment at low
concentrations also altered cell cycle progression, decreased the S and G2/M populations and at higher
concentrations increased the number of cells at sub-G1, in concordance with the increase of apoptotic cells.
Conclusion: The present study demonstrates for the first time the anticancer potential of 7-epiclusianone
against glioblastoma cells, thus meriting its further investigation as a potential therapeutic agent.
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Background
Glioblastoma (GBM) is the most aggressive and com-
mon glial tumors, and it represents the main type of
primary cancer of the central nervous system in adults
[1]. The actual standard treatment for GBM combines
tumor resection, chemotherapy with temozolomide and
radiotherapy [2]. However, despite management improve-
ments, the outcome of patients remains extremely poor,
with a mean life expectancy of approximately one year
and a 2-year overall survival of only 15.4 % [3]. Therefore,
GBM remains as one of the hardest tumors to treat,
making search for novel therapeutic options imperious.
Historically, natural products have been the founda-
tion for the development of medical compounds and
approximately 50 % of anticancer drugs are still natural
products or their derivatives [4, 5]. Brazilian biodiversity
offers many examples of common and rare plant life that
deserves to be better explored. Among the variety of plant
extracts described so far, 7-epiclusianone, a tetrapreny-
lated benzophenone isolated from the epicarp of the
native plant Garcinia brasiliensis (commonly known as
bacupari), has traditionally been used in the folk medicine
for the treatment of different diseases [6].
7-epiclusianone has shown important biological effects
including anti-inflammatory [7, 8], antinociceptive [7, 9],
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antimicrobial [10, 11], antispasmodic [12], antianaphy-
lactic [13] and antiprotozoal activities [14]. On the other
hand, the potential anticancer and apoptotic effect is
underexplored.
Based on such findings, the present study points 7-
epiclusianone as a potential antineoplastic compound,
demonstrating its influence on growth, cell cycle dynam-
ics, apoptosis and colony formation ability against glio-
blastoma cells.
Methods
Cell culture conditions
The adult human GBM cell lines U138MG (p53mut,
PTENmut, p14ARF/p16del, high MGMT levels) and
U251MG (p53wt, PTENnull, p14ARF/p16del, low MGMT
levels) were purchased from the American Type Culture
Collection, USA. Cell cultures were maintained in DMEM
(Dulbecco’s Modified Eagle’s Minimum Essential Medium,
Sigma, CA, USA) supplemented with 10 % fetal bovine
serum (FBS, Cultilab, Sao Paulo, Brazil) and grown in a
37 °C humidified incubator containing 5 % CO2.
Isolation and characterization of 7-epiclusianone
The fruits of Garcinia brasiliensis, after identification of
plant material by Dr. João Augusto Alves Meira Neto,
were collected from trees growing under controlled
conditions at the herbarium of the Federal University of
Viçosa – UFV (latitude 20°45′14″ south and longitude
42°52′55″ west), Minas Gerais state, Brazil, where the
voucher specimen (#VIC2604) is deposited.
To obtain the extract, 1000 g of G. brasiliensis fruit
epicarps were dried at 40 °C in a forced air oven for
48 h. Dried and powdered epicarps were milled and
extracted by maceration using EtOH (3 L) during 24 h.
Evaporation of the solvent under reduced pressure at
45 °C afforded the crude EtOH extract, which was
chromatographed on silica gel (230–400 mesh) col-
umn and eluted with crescent polarity mixtures of (n-hex-
ane, n-hexane-ethyl acetate (95:5), n-hexane-ethyl acetate
(80:20), n-hexane-ethyl acetate (50:50), n-hexane-ethyl
acetate (20:80) and ethanol) to give 25 fractions. These
fractions were pooled into four groups according to their
similarities after the analysis using thin layer chroma-
tography (TLC) and compared to the standard 7-epi-
clusianone previously isolated. Fractions 4–10 were
chromatographed on a silica gel (230–400 mesh) column
(8 × 100 cm) eluted with the same crescent polarity mix-
tures of n-hexane/ethyl-acetate and ethyl-acetate/ethanol
to purify the prenylated benzophenone 7-epiclusianone
with a yield of 5 %. Its structure (Fig. 1) was identified as
the polyprenylated benzophenone 7-epiclusianone [(1R,
5R,7R)-3-benzoyl-4-hydroxy-8,8-dimethyl-1,5,7-tris(3-
methylbut-2-en-1-yl) bicyclo[3.3.1]non-3-ene-2,9-dione]
using infrared, ultraviolet, and mass spectra data and
nuclear magnetic resonance spectroscopy, and its molecu-
lar geometries established using single crystal X-ray dif-
fraction (XRD) analysis. The purity level was > 99.85 % as
determined by HPLC [15, 16].
For in vitro testing, 7-epiclusianone was dissolved in
dimethyl sulfoxide (DMSO), and this stock solution was
diluted in fresh medium at the appropriated concentra-
tions immediately before of use. Vehicle alone was used
as control and the final concentration of the solvent did
not exceed 0.5 % (v/v).
Cell viability
Cells were plated on 96-wells at 5×103. After attachment
(24 h), the cells were treated for 48 h with 7-epiclusia-
none at different concentrations (10 μM, 20 μM, 30 μM
or 40 μM). The Promega® non-radioactive cell prolifera-
tion assay was used to determinate cell viability. This
assay measures the amount of formazan produced from
[3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium, inner salt, MTS)] by the
dehydrogenase enzymes of metabolically active cells (Pro-
mega, Madison, WI, USA). Thus, the quantity of formazan
produced (as measured by the absorbance at 490 nm) is
directly proportional to the number of living cells. Absorb-
ance values of the treated cells were compared with the
absorbance values of untreated cells. The experiments were
conducted in triplicate wells and repeated twice. Means ±
standard deviations (SD) were calculated. The IC50
value was determined from non-linear regression using
GraphPad Prism® (GraphPad Software, Inc., San Diego,
CA, USA).
Colony formation assay
Clonogenic formation assay was performed according to
Franken et al. [17]. Two hundred cells were seeded in
35 mm plates. After 24 h, cells were treated with 7-epi-
clusianone for 8 h and subsequently were incubated for
10 days with drug-free medium. After that period, colonies
Fig. 1 Chemical structure of 7-epiclusianone
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were fixed and stained with Giemsa (3 %). Only colonies
with >50 cells were counted by direct visual inspection
with a stereo microscope at 20× magnification. Assays
were performed in triplicate.
Cell cycle analysis
For cell cycle analysis, 2 × 105 cells were seeded on 25 cm2
flasks and treated for 48 h. Cells were then trypsinized
and fixed in 70 % ethanol, stained with propidium iodide,
and analyzed with a Guava Personal Cell Analysis system
(Guava Technologies, Hayward, CA, USA) according to
the protocol provided by the manufacturer. Percentages of
cells in sub-G1, G0/G1, S, or G2/M phase were deter-
mined and processed using the GUAVA Cytosoft software,
version 4.2.1. Assays were performed three times on
separate occasions.
Immunoblot
Both cell lines were treated with 10 μM and 40 μM for
48 h. Cells were then lysed in lysis buffer (RIPA; Sigma
Chemical Co.; 10 % protease, and 10 % phosphatase)
and stored at – 80 °C until use.
Anti-Cyclin-A (sc-751, 1:1000) and anti-GAPDH (sc-
47724, 1:1000) antibodies were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). Equal amounts
of protein (40 mg) were size-fractionated by 12 %
SDS-PAGE, blotted onto a nitrocellulose membrane
(Amersham Hybond™ ECL™, GE Healthcare) and incu-
bated in Tris-buffered saline-0.1 % Tween-20 (TBS-T)
containing 5 % (w/v) dried non-fat milk for 1 h at room
temperature. After blocking and washing in TBS-T with
0.1 % Tween 20 for 30 min, each membrane was incu-
bated overnight with appropriately diluted primary anti-
bodies. After incubation, the membrane was washed three
times in TPBS-T with 0.1 % Tween 20 and bound to a
biotin-labeled horseradish peroxidase–conjugated species-
specific secondary antibody (AbCam, San Francisco, CA,
USA). The complexes were visualized using an enhanced
chemiluminescence reagent (ECL; Amersham, Uppsala,
Sweden).
Apoptosis assay
Apoptotic cell death was determined by annexin V fluor-
escein isothiocyanate labeling (BD Biosciences Pharmi-
gen, San Jose, CA, USA). Briefly, cells were grown in
25 cm2 tissue culture flasks and treated with 7-epiclusia-
none for 48 h cells were then trypsinized and centrifuged
at 1,000 rpm for 5 min at 4 °C, washed with ice-cold
PBS, and then 2 × 105 cells were resuspended in 300 μl
of 1× annexin V binding buffer (BD Biosciences Pharmi-
gen). Cells were stained with 5 μl annexin V fluorescein
isothiocyanate and 50 μl of propidium iodide (50 μmol/L),
and immediately read. At least 10,000 events were
analyzed using a BD FACSCalibur flow cytometer
(BD Biosciences Pharmigen). Assays were performed
in triplicate.
Apoptotic cell death was also determined by analysis
of caspase activation. 5 × 104 cells were seeded on 6-well
plates containing 3 mL of culture medium. After 24 h,
the medium was replaced and cells treated with 40 μM
of 7-epiclusianone or vehicle only and cultured for add-
itional 48 h. Caspase activation was determined using
the NucView 488 Caspase-3 Detection in Living Cells kit
(Biotium Inc. #30029) according to the manufacturer’s
instructions. Five hundred nuclei per treatment were
analyzed by fluorescence microscopy.
Statistical analysis
Statistical analyses were performed using the SigmaStat
3.5 software (Jandel Scientific Company, San Rafael, CA,
USA). One-way repeated measures analysis of variance
followed by the Holm–Sidak pairwise multiple compari-
son were used to establish any significant differences
between groups. For caspase activation analysis, Student’s
t-test was used. All tests were carried out for α = 0.05.
Results and discussion
7-epiclusianone significantly inhibited cell viability in
both GBM lines tested when compared to control in a
concentration-dependent manner (p < 0.01) (Fig. 2a and
b). The concentration required to induce 50 % inhibition
of cell growth (IC50) after 48 h of treatment was 23.00 ±
0.32 μM in U251MG (r2 = 0.99) and 18.52 ± 0.50 μM
(r2 = 0.98) in U138MG.
7-epiclusianone treatment also reduced the colony
formation capacity for both cell GBM lines when
compared to control at 20 μM and 30 μM (p < 0.01),
demonstrating long-term effects even after removal of
the drug (Fig. 2c-f ).
Cell cycle analysis showed that 7-epiclusianone is effect-
ive in inducing cell cycle arrest and/or cell death, however
these effects are concentration-dependent. Increased G1
population with concomitant decreased G2/M popula-
tions was observed in U251MG cultures treated with 7-
epiclusianone at 10 μM, in U138MG there were also
decrease in S and G2/M populations. When higher con-
centration of 7-epiclusianone was used (40 μM), a signifi-
cant increase in Sub-G1 population was observed for both
cell lines (Fig. 3a and b, Table 1).
Cell cycle arrest was accompanied by decreased CCNA
(cyclin A) expression (Fig. 3c), which is a cell cycle regu-
latory protein repressed during G1 phase and induced at
S-phase [18]. Furthermore, ectopically expressed cyclin
A overcomes G1 arrest in vitro [19], suggesting that
7-epiclusianone induced G1-phase arrest is at least
partially caused by cyclin A down regulation.
Besides G1 arrest, after high dose treatment (40 μM) cell
cycle analysis showed increase in the sub-G1 population.
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Considering the results obtained, we also investigated
whether cell death detected would be due to apoptosis
induction. Annexin V was used for monitoring cells in
apoptosis and the 40 μM treatment mediated a significant
increase of positive cells to 18.8 % for U251MG and to
21.8 % for U138MG (p < 0.01) after 48 h (Fig. 4a and c-f).
This result was also confirmed by increased level of cell
caspase-3 activity (Fig. 4b). Additionally, the ratio of
proliferation and apoptosis (annexin V positive cells) in
GBM cells were 22.83 (U251MG) and 19.92 (U138MG)
before treatment, after 40 μM 7-epiclusianone exposition,
the ratio strongly decreased for 1.05 in U251MG and 0.48
in U138MG cell lines.
The Clusiaceae family is frequently found in tropical
areas and comprises about 40 genera and 1200 species,
with about 400 species of Garcinia genius [10]. Several
benzophenones extracted from Garcinia spp. such as
G. indica, G. xanthochymus, G. purpurea, G. macrophylla,
G. mangostana, G. pyrifera, and G. yunnanensis have pre-
viously exhibited cytotoxic activity against various tumor
types, including prostate, ovarian, colon, leukemia and
cervical cancer [20–22].
Fig. 2 7-epiclusianone treatments inhibit growth and clonogenic capacity. a, b Growth inhibition in U251MG and U138MG cell lines treated with
7-epiclusianone at the indicated concentrations for 48 h (MTS assay); (c-f) 7-epiclusianone potently abrogated the clonogenic capacity of both
glioblastoma cell lines (*p < 0.01)
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Garcinia brasiliensis fruits have long been used as an
alternative treatment in Brazilian folk medicine. In the
present study, we showed that its derivative, 7-epiclusia-
none, diminishes cell viability, alters cell cycle progres-
sion, and increases apoptosis in GBM, one of the most
aggressive tumors and with limited treatment options.
So far, few articles suggested a potential antiprolifer-
ative effect of G. brasiliensis after 7-epiclusianone
treatment of human cancer cell lines, including mel-
anoma, kidney, ovarian, prostate and lung [23, 24].
In A549 lung cells, 7-epiclusianone treatment also
induced apoptosis and cell cycle arrest in G1/S transi-
tion. Additionally, the cytotoxic activity of 7-epiclusia-
none in normal fibroblasts (CCD-1059Sk) was also
evaluated and IC50 value was approximately 58 μM,
2.5 and 3.2 times higher than for the cancer cell lines
tested herein, U251MG and U138MG [24].
Similar cytotoxic activities have been described for an-
other polyisoprenylated benzophenone isolated and puri-
fied from G. xanthochymus which arrests the cell-cycle in
G1-phase and induces apoptosis in colon cancer cell lines
[25]. Apoptosis has also been evidenced after treatment
with benzophenones extracted from G. xanthochymus
[26], from G. yunnanensis [27], and from G. purpurea [28]
in many solid tumors and leukemia cells. Comparatively,
Garcinol (obtained from G. indica), the most cited natural
benzophenone in the literature, has repeatedly demon-
strated to decrease cell viability and induce apoptosis of
cancer cells [29, 30]. This compound also decreased the
colony forming ability of prostate and pancreatic cancer
cell lines, suggesting a possible application against meta-
static disease [31].
It is well known that GBM treatment outcome is
often hampered by the inherent invasive properties of
the tumor, thus the clonogenic capacity of cells after
treatment is an important aspect for testing potential
therapeutic compounds. Herein, 7-epiclusianone treat-
ment for only 8 h significantly reduced the colony
formation capacity of GBM cells, demonstrating long-
term effects even after removal of the drug.
Another benzophenone derived from the Malaysian G.
hombroniana, 2,3′,4,5’-tetrahydroxy-6-methoxybenzophe-
none, has also presented cytotoxic effects on the DBTRG
cell line which is derived from a 56-year-old woman
with GBM. Most interestingly, the compound was found
to be more toxic towards glioma cells as compared to
other cell lines of different origin including MCF-7 (breast
Table 1 Cell cycle analysis of glioblastoma cell lines after
treatment with 7-epiclusianone
U251MG U138MG
Sub-G1 (%)
Control 6.35 ±0.92 6.45 ±3.68
10 μM 5.92 ±3.00 13.98 ±6.14
20 μM 7.80 ±1.00 12.99 ±0.81
30 μM 9.88 ±1.09 15.66 ±2.82
40 μM 14.74 ±0.94* 22.50 ±2.45*
G1 (%)
Control 54.97 ±2.76 65.54 ±3.86
10 μM 68.94 ±2.34* 65.70 ±4.20
20 μM 59.67 ±3.82 55.99 ±0.54*
30 μM 57.02 ±2.97 54.92 ±0.68*
40 μM 45.77 ±1.49* 50.72 ±2.58*
S (%)
Control 5.07 ±1.07 6.83 ±0.73
10 μM 3.59 ±1.63 4.32 ±0.76*
20 μM 6.77 ±0.41 7.44 ±0.75
30 μM 6.93 ±0.39 7.45 ±0.92
40 μM 6.23 ±1.92 4.74 ±0.17*
G2/M (%)
Control 33.79 ±2.34 21.24 ±0.50
10 μM 21.36 ±1.05* 17.25 ±3.05*
20 μM 25.44 ±2.99* 23.51 ±0.90
30 μM 26.10 ±1.66* 22.32 ±3.65
40 μM 33.62 ±2.28 21.99 ±1.92
Percentages of cells in Sub-G1, G1, S and G2/M phases are expressed as
mean ± standard deviation
*p < 0.05
Fig. 3 7-epiclusianone treatments alter cell cycle progression. Cell cycle progression in U251MG (a) and U138MG (b) glioblastoma cell lines after
48 h; c Cyclin A and GAPDH expression after 48 h. *p < 0.01
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cancer), U2OS (osteosarcoma) and PC-3 (prostate cancer)
[32].
In the present study, we investigated 7-epiclusia-
none in glioma cells mainly due to extremely poor
outcome of patients caused for few chemotherapy op-
tions available. However, the numerous antitumor ef-
fects described for other natural benzophenone
recommend future investigation of 7-epiclusianone
also in other tumor types.
Even though the mechanisms through which benzo-
phenones impair cell growth and induce apoptosis are
still under investigation, some studies suggest an anti-
microtubule action during cell division or the intensifi-
cation of caspase-3 activity [25, 28, 29]. Other mechanisms
such as inhibition of histone acetyltranferase activity [33],
inhibition of kinase activity [34], or inducing DNA damage
[35] have also been suggested.
Conclusions
The results presented herein point 7-epiclusianone as an
important natural benzophenone with antineoplastic ac-
tivity in a glioblastoma model, a tumor with inherent
chemoresistance, demonstrating influence on cell
growth, cell cycle dynamics, apoptosis and colony forma-
tion ability. However, further studies should be con-
ducted to investigate the molecular mechanisms
underneath the cytotoxic activity of this benzophenone,
pharmacokinetics in human condition and the prospect
of using it for the treatment of other tumor types.
Fig. 4 7-epiclusianone treatments alter apoptotic rates. a, c-f Increased Annexin V positive cells after treatment with 7-epi-clusianone in glioblastoma
(GBM) cells lines; b Increased caspase-3 activation rates after treatment with 7-epiclusianone in GBM cells lines (data are expressed as the mean-SD of
all cell lines). *p < 0.05, **p < 0.01. PI, propidium iodide
Sales et al. BMC Complementary and Alternative Medicine  (2015) 15:393 Page 6 of 8
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JCO and MI designed the study and supervised the project; MHS collected
the plant and carried out the extraction; LS, JAP, KSB, MSB, JCO performed
laboratory analyses; CAS and LGT provided reagents and helped to supervise
the research. All authors read and approved the final version of the
manuscript.
Acknowledgements
This study was supported by the following Public Research Agencies:
FAPEMIG, FAPESP, CNPq and CAPES.
Author details
1Institute of Natural Sciences, Federal University of Alfenas, Rua Gabriel
Monteiro da Silva, 700, 37130-000 Alfenas, MG, Brazil. 2Molecular Oncology
Center, Sirio Libanes Hospital, Rua Dona Adma Jafet, 115, 01308-050 Sao
Paulo, SP, Brazil. 3Department of Paediatrics, Ribeirão Preto Medical School,
University of São Paulo, Av. Bandeirantes, 3900, 14049-900 Ribeirão Preto, SP,
Brazil. 4Department of Biology, Faculty of Philosophy, Sciences and Letters at
Ribeirão Preto, University of São Paulo, Av. Bandeirantes, 3900, 14049-900
Ribeirão Preto, SP, Brazil. 5Institute of Chemistry, Federal University of Viçosa,
Avenida Peter Henry Rolfs, s/n, 36570-900 Viçosa, MG, Brazil. 6Institute of
Biomedical Sciences, Federal University of Alfenas, Rua Gabriel Monteiro da
Silva, 700, 37130-000 Alfenas, MG, Brazil.
Received: 23 July 2015 Accepted: 12 October 2015
References
1. Lim SK, Llaguno SR, McKay RM, Parada LF. Glioblastoma multiforme: a
perspective on recent findings in human cancer and mouse models. BMB
Rep. 2011;44(3):158–64.
2. Gilbert MR. Recurrent glioblastoma: a fresh look at current therapies and
emerging novel approaches. Semin Oncol. 2011;38 Suppl 4:S21–33.
3. Guckenberger M, Mayer M, Buttmann M, Vince GH, Sweeney RA, Flentje M.
Prolonged survival when temozolomide is added to accelerated
radiotherapy for glioblastoma multiforme. Strahlenther Onkol.
2011;187(9):548–54.
4. Newman DJ, Cragg GM. Natural products as sources of new drugs over the
30 years from 1981 to 2010. J Nat Prod. 2012;75(3):311–35.
5. Gul MZ, Ahmad F, Kondapi AK, Qureshi IA, Ghazi IA. Antioxidant and
antiproliferative activities of Abrus precatorius leaf extracts-an in vitro study.
BMC Complement Altern Med. 2013;13:53.
6. Corrêa MP. Dicionário das Plantas Úteis do Brasil e das Plantas Exóticas
Cultivadas. 1st ed. Rio de Janeiro: Imprensa Nacional; 1978.
7. Santa-Cecília FV, Freitas LA, Vilela FC, Veloso Cde C, da Rocha CQ, Moreira
ME, et al. Antinociceptive and anti-inflammatory properties of 7-
epiclusianone, a prenylated benzophenone from Garcinia brasiliensis. Eur J
Pharmacol. 2011;670(1):280–5.
8. Santa-Cecília FV, Santos GB, Fuzissaki CN, Derogis PB, Freitas LA, Gontijo VS,
et al. 7-epiclusianone, the natural prenylated benzophenone, inhibits
superoxide anions in the neutrophil respiratory burst. J Med Food.
2012;15(2):200–5.
9. Santa-Cecília FV, Vilela FC, da Rocha CQ, Dias DF, Cavalcante GP, Freitas LA,
et al. Anti-inflammatory and antinociceptive effects of Garcinia brasiliensis.
J Ethnopharmacol. 2011;133(2):467–73.
10. Naldoni FJ, Claudino AL, Cruz JW, Chavasco JK, Faria e Silva PM, Veloso MP,
et al. Antimicrobial activity of benzophenones and extracts from the fruits
of Garcinia brasiliensis. J Med Food. 2009;12(2):403–7.
11. Murata RM, Branco-de-Almeida LS, Franco EM, Yatsuda R, dos Santos MH,
de Alencar SM, et al. Inhibition of Streptococcus mutans biofilm
accumulation and development of dental caries in vivo by 7-epiclusianone
and fluoride. Biofouling. 2010;26(7):865–72.
12. Coelho LP, Serra MF, Pires AL, Cordeiro RS, Rodrigues e Silva PM, dos Santos
MH, et al. 7-Epiclusianone, a tetraprenylated benzophenone, relaxes airway
smooth muscle through activation of the nitric oxide-cGMP pathway.
J Pharmacol Exp Ther. 2008;327(1):206–14.
13. Neves JS, Coelho LP, Cordeiro RS, Veloso MP, Rodrigues e Silva PM, dos
Santos MH, et al. Antianaphylactic properties of 7-epiclusianone, a
tetraprenylated benzophenone isolated from Garcinia brasiliensis. Planta
Med. 2007;73(7):644–9.
14. Pereira IO, Marques MJ, Pavan AL, Codonho BS, Barbiéri CL, Beijo LA, et al.
Leishmanicidal activity of benzophenones and extracts from Garcinia
brasiliensis Mart. fruits. Phytomedicine. 2010;17(5):339–45.
15. Piccinelli AL, Cuesta-Rubio O, Chica MB, Mahmood N, Pagano B, Pavone
M, et al. Structural revision of clusianone and 7-epiclusianone and
anti-HIV activity of polyisoprenylated benzophenones. Tetrahedron.
2005;61:8206–11.
16. Derogis PB, Martins FT, de Souza TC, de C Moreira ME, Souza Filho
JD, Doriguetto AC, et al. Complete assignment of the 1H and 13C
NMR spectra of garciniaphenone and keto-enol equilibrium
statements for prenylated benzophenones. Magn Reson Chem.
2008;46(3):278–82.
17. Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic
assay of cells in vitro. Nat Protoc. 2006;1(5):2315–9.
18. Blanchard JM. Cyclin A2 transcriptional regulation: modulation of cell cycle
control at the G1/S transition by peripheral cues. Biochem Pharmacol.
2000;60:1179–84.
19. Weiss C, Faust D, Schreck I, Ruff A, Farwerck T, Melenberg A, et al. TCDD
deregulates contact inhibition in rat liver oval cells via Ah receptor, JunD
and cyclin A. Oncogene. 2008;27:2198–207.
20. Acuña UM, Jancovski N, Kennelly EJ. Polyisoprenylated benzophenones
from Clusiaceae: potential drugs and lead compounds. Curr Top Med
Chem. 2009;9(16):1560–80.
21. Aisha AF, Abu-Salah KM, Ismail Z, Majid AM. In vitro and in vivo anti-colon
cancer effects of Garcinia mangostana xanthones extract. BMC Complement
Altern Med. 2012;12:104.
22. Biloa Messi B, Ho R, Meli Lannang A, Cressend D, Perron K, Nkengfack AE, et
al. Isolation and biological activity of compounds from Garcinia preussii.
Pharm Biol. 2014;52(6):706–11.
23. Murata RM, Yatsuda R, dos Santos MH, Kohn LK, Martins FT, Nagem TJ, et al.
Antiproliferative effect of benzophenones and their influence on cathepsin
activity. Phytother Res. 2010;24(3):379–83.
24. Ionta M, Ferreira-Silva GA, Niero EL, Costa ÉD, Martens AA, Rosa W, et al.
7-Epiclusianone, a Benzophenone Extracted from Garcinia brasiliensis
(Clusiaceae), Induces Cell Cycle Arrest in G1/S Transition in A549 Cells.
Molecules. 2015;20(7):12804–16.
25. Protiva P, Hopkins ME, Baggett S, Yang H, Lipkin M, Holt PR, et al. Growth
inhibition of colon cancer cells by polyisoprenylated benzophenones is
associated with induction of the endoplasmic reticulum response. Int J
Cancer. 2008;123(3):687–94.
26. Baggett S, Protiva P, Mazzola EP, Yang H, Ressler ET, Basile MJ, et al.
Bioactive benzophenones from Garcinia xanthochymus fruits. J Nat Prod.
2005;68(3):354–60.
27. Xu G, Feng C, Zhou Y, Han QB, Qiao CF, Huang SX, et al. Bioassay and
ultraperformance liquid chromatography/mass spectrometry guided
isolation of apoptosis-inducing benzophenones and xanthone from the
pericarp of Garcinia yunnanensis Hu. J Agric Food Chem.
2008;56(23):11144–50.
28. Matsumoto K, Akao Y, Kobayashi E, Ito T, Ohguchi K, Tanaka T, et al.
Cytotoxic benzophenone derivatives from Garcinia species display a strong
apoptosis-inducing effect against human leukemia cell lines. Biol Pharm
Bull. 2003;26(4):569–71.
29. Hong J, Kwon SJ, Sang S, Ju J, Zhou JN, Ho CT, et al. Effects of garcinol and
its derivatives on intestinal cell growth: Inhibitory effects and autoxidation-
dependent growth-stimulatory effects. Free Radic Biol Med.
2007;42(8):1211–21.
30. Parasramka MA, Gupta SV. Synergistic effect of garcinol and curcumin on
antiproliferative and apoptotic activity in pancreatic cancer cells. J Oncol.
2012;2012:709739.
31. Ahmad A, Wang Z, Wojewoda C, Ali R, Kong D, Maitah MY, et al. Garcinol-
induced apoptosis in prostate and pancreatic cancer cells is mediated by
NF- kappaB signaling. Front Biosci (Elite Ed). 2011;3:1483–92.
32. Jamila N, Khairuddean M, Yaacob NS, Kamal NN, Osman H, Khan SN, et al.
Cytotoxic benzophenone and triterpene from Garcinia hombroniana. Bioorg
Chem. 2014;54:60–7.
33. Balasubramanyam K, Altaf M, Varier RA, Swaminathan V, Ravindran A,
Sadhale PP, et al. Polyisoprenylated benzophenone, garcinol, a natural
histone acetyltransferase inhibitor, represses chromatin transcription and
alters global gene expression. J Biol Chem. 2004;279(32):33716–26.
Sales et al. BMC Complementary and Alternative Medicine  (2015) 15:393 Page 7 of 8
34. Díaz-Carballo D, Malak S, Freistühler M, Elmaagacli A, Bardenheuer W,
Reusch HP. Nemorosone blocks proliferation and induces apoptosis in
leukemia cells. Int J Clin Pharmacol Ther. 2008;46(8):428–39.
35. Wu CC, Yen MH, Yang SC, Lin CN. Phloroglucinols with antioxidant activity
and xanthonolignoids from the heartwood of Hypericum geminiflorum.
J Nat Prod. 2008;71(6):1027–31.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Sales et al. BMC Complementary and Alternative Medicine  (2015) 15:393 Page 8 of 8
